Nov 20, 2025, 13:19
Combining HIFU and Pharmacotherapy Shows Promise for Adenomyosis-Related Infertility – EJOG
European Journal Obstetrics and Gynecology (EJOG) shared a post on LinkedIn:
“Individualized strategies and future perspectives of high-intensity focused ultrasound combined with pharmacological treatment for adenomyosis-associated infertility: A narrative review
Highlights
- HIFU and medication together may improve pregnancy outcomes in adenomyosis.
- Combining therapies can better reduce pain and preserve the uterus.
- Tailored treatment plans support both fertility and symptom relief.
- Review identifies key challenges in current fertility-focused strategies.
- Future research must define safe, effective protocols for childbearing women.”
Title: Individualized strategies and future perspectives of high-intensity focused ultrasound combined with pharmacological treatment for adenomyosis-associated infertility: A narrative review
Authors: Yong Huang, Lu Yao, Bei Zhuo
Read the full article.
Stay updated on all scientific advances in the field of fertility with Fertility News.
-
Apr 30, 2026, 18:45AI in Ultrasound Follicular Monitoring Moves Toward Clinical Decision Support – RBMO
-
Apr 30, 2026, 11:42ASRM Encourages Registration for Conference on Practice Growth and Innovation
-
Apr 30, 2026, 11:26ESHRE and ALPHA Launch Global Survey to Update ART Laboratory KPIs
-
Apr 30, 2026, 11:10Susanne Johnson: Advanced Gynaecology Ultrasound Course Day 2
-
Apr 30, 2026, 11:02Platelets Reduce Oxidative Stress Damage in Human Endometrial Stromal Cells in Vitro – RBMO
-
Apr 30, 2026, 10:57GREEG Day 2026: Elevate Your Ultrasound Expertise – GREEG
-
Apr 30, 2026, 10:49Up to Two-Thirds of Elite Female Athletes Experience Irregular Periods – Fertility Plus
-
Apr 30, 2026, 10:47Applications for the ESHRE5 Young Ambassadors 2026 are Still OPEN, But Not for Long! – ESHRE
-
Apr 30, 2026, 10:42The Link Between Lifestyle and Anti-Müllerian Hormone – RBMO